Unique ID issued by UMIN | UMIN000029147 |
---|---|
Receipt number | R000033327 |
Scientific Title | Multicenter Prospective Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer |
Date of disclosure of the study information | 2017/09/30 |
Last modified on | 2021/09/24 13:37:51 |
Multicenter Prospective Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
Multicenter Prospective Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
Multicenter Prospective Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
Multicenter Prospective Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
Japan |
pancreatic cancer
Hepato-biliary-pancreatic medicine | Hepato-biliary-pancreatic surgery | Radiology |
Malignancy
NO
To evaluate the efficacy and safety of neoadjuvant chemotherapy for borderline pancreatic cancer.
To verify proper regimen, administration period and predictive biomarker.
Safety,Efficacy
R0 resection ratio
Observational
20 | years-old | <= |
Not applicable |
Male and Female
Borderline resectable pancreatic cancer who are planning neoadjuvant chemotherapy with the following criteria
1)no gender
2)age over 20 years old
3)the patients who gained written consent by the patient's free will with sufficient understanding after receiving sufficient explanation for the participation of this study,
Patients judged unsuitable as research subjects
50
1st name | |
Middle name | |
Last name | Hiroaki Nagano |
Yamaguchi University Graduate School of Medicine
Department of Gastroenterological, Breast and Endocrine Surgery
1-1-1 Minami-Kogushi, Ube, Yamaguchi
0836-22-2264
hnagano@yamaguchi-u.ac.jp
1st name | |
Middle name | |
Last name | Hiroto Matsui |
Yamaguchi University Graduate School of Medicine
Department of Gastroenterological, Breast and Endocrine Surgery
1-1-1 Minami-Kogushi, Ube, Yamaguchi
0836-22-2264
matsui-h@yamaguchi-u.ac.jp
Yamaguchi Pancreatic / Biliary Disease Study Group
Yamaguchi Pancreatic / Biliary Disease Study Group
Other
NO
2017 | Year | 09 | Month | 30 | Day |
Unpublished
No longer recruiting
2017 | Year | 08 | Month | 01 | Day |
2017 | Year | 08 | Month | 30 | Day |
2017 | Year | 09 | Month | 01 | Day |
2020 | Year | 08 | Month | 31 | Day |
collecting information in routine practice of borderline resectable pancreatic cancer patient undergoing neoadjuvant chemotherapy, safety
and efficacy will be evaluated.
2017 | Year | 09 | Month | 14 | Day |
2021 | Year | 09 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033327
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |